These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 10465535)
1. Structure-activity relationship of N-methyl-N-aralkyl-peptidylamines as novel N-type calcium channel blockers. Hu LY; Ryder TR; Rafferty MF; Dooley DJ; Geer JJ; Lotarski SM; Miljanich GP; Millerman E; Rock DM; Stoehr SJ; Szoke BG; Taylor CP; Vartanian MG Bioorg Med Chem Lett; 1999 Aug; 9(15):2151-6. PubMed ID: 10465535 [TBL] [Abstract][Full Text] [Related]
2. N,N-dialkyl-dipeptidylamines as novel N-type calcium channel blockers. Hu LY; Ryder TR; Rafferty MF; Cody WL; Lotarski SM; Miljanich GP; Millerman E; Rock DM; Song Y; Stoehr SJ; Taylor CP; Weber ML; Szoke BG; Vartanian MG Bioorg Med Chem Lett; 1999 Mar; 9(6):907-12. PubMed ID: 10206559 [TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship at the leucine side chain in a series of N,N-dialkyldipeptidyl-amines as N-type calcium channel blockers. Ryder TR; Hu LY; Rafferty MF; Lotarski SM; Rock DM; Stoehr SJ; Taylor CP; Weber ML; Miljanich GP; Millerman E; Szoke BG Drug Des Discov; 2000; 16(4):317-22. PubMed ID: 10807036 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity study and analgesic efficacy of amino acid derivatives as N-type calcium channel blockers. Seko T; Kato M; Kohno H; Ono S; Hashimura K; Takimizu H; Nakai K; Maegawa H; Katsube N; Toda M Bioorg Med Chem Lett; 2001 Aug; 11(16):2067-70. PubMed ID: 11514140 [TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship at the proximal phenyl group in a series of non-peptidyl N-type calcium channel antagonists. Ryder TR; Hu LY; Rafferty MF; Lotarski SM; Rock DM; Stoehr SJ; Taylor CP; Weber ML; Miljanich GP; Millerman E; Szoke BG Bioorg Med Chem Lett; 1999 Aug; 9(16):2453-8. PubMed ID: 10476886 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity study of L-amino acid-based N-type calcium channel blockers. Seko T; Kato M; Kohno H; Ono S; Hashimura K; Takimizu H; Nakai K; Maegawa H; Katsube N; Toda M Bioorg Med Chem; 2003 Apr; 11(8):1901-13. PubMed ID: 12659776 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers. Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of a series of 4-benzyloxyaniline analogues as neuronal N-type calcium channel blockers with improved anticonvulsant and analgesic properties. Hu LY; Ryder TR; Rafferty MF; Feng MR; Lotarski SM; Rock DM; Sinz M; Stoehr SJ; Taylor CP; Weber ML; Bowersox SS; Miljanich GP; Millerman E; Wang YX; Szoke BG J Med Chem; 1999 Oct; 42(20):4239-49. PubMed ID: 10514294 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of substituted 4-(OBz)phenylalanine derivatives as novel N-type calcium channel blockers. Hu LY; Ryder TR; Nikam SS; Millerman E; Szoke BG; Rafferty MF Bioorg Med Chem Lett; 1999 Apr; 9(8):1121-6. PubMed ID: 10328297 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological identification of a novel Ca2+ channel in chicken brain synaptosomes. Lundy PM; Hamilton MG; Frew R Brain Res; 1994 Apr; 643(1-2):204-10. PubMed ID: 8032915 [TBL] [Abstract][Full Text] [Related]
11. Structure-activity study of L-cysteine-based N-type calcium channel blockers: optimization of N- and C-terminal substituents. Seko T; Kato M; Kohno H; Ono S; Hashimura K; Takimizu H; Nakai K; Maegawa H; Katsube N; Toda M Bioorg Med Chem Lett; 2002 Mar; 12(6):915-8. PubMed ID: 11958993 [TBL] [Abstract][Full Text] [Related]
12. Multiple parallel synthesis of N,N-dialkyldipeptidylamines as N-type calcium channel blockers. Ryder TR; Hu LY; Rafferty MF; Millerman E; Szoke BG; Tarczy-Hornoch K Bioorg Med Chem Lett; 1999 Jul; 9(13):1813-8. PubMed ID: 10406647 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and SAR of 4-aminocyclopentapyrrolidines as N-type Ca²⁺ channel blockers with analgesic activity. Beebe X; Darczak D; Henry RF; Vortherms T; Janis R; Namovic M; Donnelly-Roberts D; Kage KL; Surowy C; Milicic I; Niforatos W; Swensen A; Marsh KC; Wetter JM; Franklin P; Baker S; Zhong C; Simler G; Gomez E; Boyce-Rustay JM; Zhu CZ; Stewart AO; Jarvis MF; Scott VE Bioorg Med Chem; 2012 Jul; 20(13):4128-39. PubMed ID: 22626552 [TBL] [Abstract][Full Text] [Related]
15. Functional and pharmacological consequences of the distribution of voltage-gated calcium channels in the renal blood vessels. Hansen PB Acta Physiol (Oxf); 2013 Apr; 207(4):690-9. PubMed ID: 23351056 [TBL] [Abstract][Full Text] [Related]
16. Spontaneous muscle action potentials are blocked by N-type and P/Q-calcium channels blockers in the rat spinal cord-muscle co-culture system. Taguchi K; Shiina M; Shibata K; Utsunomiya I; Miyatake T Brain Res; 2005 Feb; 1034(1-2):62-70. PubMed ID: 15713260 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and pharmacological evaluation of conformationally constrained analogues of N,N'-diaryl- and N-aryl-N-aralkylguanidines as potent inhibitors of neuronal Na+ channels. Maillard MC; Perlman ME; Amitay O; Baxter D; Berlove D; Connaughton S; Fischer JB; Guo JQ; Hu LY; McBurney RN; Nagy PI; Subbarao K; Yost EA; Zhang L; Durant GJ J Med Chem; 1998 Jul; 41(16):3048-61. PubMed ID: 9685245 [TBL] [Abstract][Full Text] [Related]
18. Novel potent and selective calcium-release-activated calcium (CRAC) channel inhibitors. Part 1: synthesis and inhibitory activity of 5-(1-methyl-3-trifluoromethyl-1H-pyrazol-5-yl)-2-thiophenecarboxamides. Yonetoku Y; Kubota H; Okamoto Y; Toyoshima A; Funatsu M; Ishikawa J; Takeuchi M; Ohta M; Tsukamoto S Bioorg Med Chem; 2006 Jul; 14(14):4750-60. PubMed ID: 16580212 [TBL] [Abstract][Full Text] [Related]
19. Novel potent and selective calcium-release-activated calcium (CRAC) channel inhibitors. Part 2: Synthesis and inhibitory activity of aryl-3-trifluoromethylpyrazoles. Yonetoku Y; Kubota H; Okamoto Y; Ishikawa J; Takeuchi M; Ohta M; Tsukamoto S Bioorg Med Chem; 2006 Aug; 14(15):5370-83. PubMed ID: 16616503 [TBL] [Abstract][Full Text] [Related]
20. Discovery and structural optimization of 1-phenyl-3-(1-phenylethyl)urea derivatives as novel inhibitors of CRAC channel. Zhang HZ; Xu XL; Chen HY; Ali S; Wang D; Yu JW; Xu T; Nan FJ Acta Pharmacol Sin; 2015 Sep; 36(9):1137-44. PubMed ID: 26256403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]